Abstract
The human cytomegalovirus (CMV) preferentially infects tumor tissues, and the accumulated CMV immediate early (IE) antigen may lead to tumor promotion and progression. The development of strategies to inhibit the expression and/or function of human IE antigen is an important goal to prevent and treat certain forms of cancer associated with human CMV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
